SEC 13F Intelligence

Boxer Capital, LLC / PTCT

Boxer Capital, LLC’s Ptc Therapeutics Inc Position

Does Boxer Capital, LLC own Ptc Therapeutics Inc (PTCT)? Not currently — the last reported position was 1.00M shares worth $34M in Q3 2019; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$34M
Q3 2019
Shares
1.00M
% of Portfolio
+2.45%
Quarters Held
4
position exited

Position History PTCT

Reported value by quarter
Q4 ’18: $74MQ4 ’18Q1 ’19: $38MQ1 ’19Q2 ’19: $45MQ2 ’19Q3 ’19: $34MQ3 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20191.00M$34M+2.45%
Q2 20191.00M$45M+3.87%
Q1 20191.00M$38M+4.35%
Q4 20182.15M$74M+9.14%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of PTCT.